CyberLiver emerged from a conversation between our co-founders that highlighted the huge burden of liver disease and how it is emerging as the world’s fastest growing disease. Melding decades of hepatology research, expertise in software technology and understanding of global health markets, CyberLiver’s journey began, applying a pharma-grade approach to the development of software to treat liver disease.

We are assembling a world-class team of global experts in management, clinical strategy, software technology, intellectual property, regulatory strategy, financial management and most importantly commercial models.